Today: 4 February 2026
Subscribe
Browse Category

Investing News 10 December 2025

Plug Power Stock (PLUG) in December 2025: NASA Contract, Fresh Cash and a High‑Risk Outlook for Investors

Plug Power Stock (PLUG) in December 2025: NASA Contract, Fresh Cash and a High‑Risk Outlook for Investors

Where Plug Power Stock Stands on December 10, 2025 Plug Power Inc. (NASDAQ: PLUG), the hydrogen fuel‑cell and electrolyzer company, remains one of the most volatile names in clean energy. As of the latest trade on December 10, 2025, PLUG is changing hands at about $2.19 per share, with an intraday range between roughly $2.16 and $2.24 and volume north…
10 December 2025
·····
Goldman Sachs (GS) Stock Hits 52‑Week High as Dealmaking Surges – What Investors Need to Know on December 10, 2025

Goldman Sachs (GS) Stock Hits 52‑Week High as Dealmaking Surges – What Investors Need to Know on December 10, 2025

Key points Goldman Sachs stock today: price, valuation and performance As of the afternoon session on December 10, 2025, shares of The Goldman Sachs Group, Inc. (NYSE: GS) are trading around $879 after hitting an intraday high of about $883.72, a fresh 52‑week high. MarketBeat According to MarketBeat data, GS most recently: MarketBeat Reuters notes that as of yesterday, Goldman’s…
10 December 2025
·····
Big Tech Stocks After the Bell on December 10, 2025: Microsoft Surges, Amazon Slips as AI and Fed Jitters Collide

Big Tech Stocks After the Bell on December 10, 2025: Microsoft Surges, Amazon Slips as AI and Fed Jitters Collide

NEW YORK — December 10, 2025. Big Tech stocks delivered a mixed message in after‑hours trading on Wednesday as investors waited for the Federal Reserve’s final rate decision of 2025 and weighed fresh AI‑driven forecasts for the “Magnificent Seven.” During the regular session, U.S. indexes were broadly cautious: the S&P 500 hovered around flat, the Nasdaq 100 dipped roughly 0.2%, and…
10 December 2025
····
iRobot (IRBT) Stock Today: Short Squeeze Fireworks vs. Bankruptcy Fears – December 10, 2025

iRobot (IRBT) Stock Today: Short Squeeze Fireworks vs. Bankruptcy Fears – December 10, 2025

Updated December 10, 2025 iRobot Corporation (NASDAQ: IRBT), the Roomba maker once worth nearly $200 per share, is again one of the most volatile names in U.S. markets. As of mid‑afternoon on December 10, 2025, IRBT trades around $4.26, up about 20% on the day, after a string of sharp moves driven by speculation over U.S. robotics policy, aggressive short…
10 December 2025
·····
Eli Lilly (LLY) Stock Near $1 Trillion: Zepbound Price Cuts, New $6B Plant and 2026 Dividend Hike – Is It Still a Buy?

Eli Lilly (LLY) Stock Near $1 Trillion: Zepbound Price Cuts, New $6B Plant and 2026 Dividend Hike – Is It Still a Buy?

Updated: December 10, 2025 Key takeaways LLY stock today: price, performance and valuation snapshot As of mid‑day trading on December 10, 2025, Eli Lilly (NYSE: LLY) is changing hands at around $980 per share, down slightly on the day and just below its recent all‑time high above $1,050. That price values Lilly at roughly $930–$1,000+ billion in market cap, depending…
10 December 2025
·····
AutoZone (AZO) Stock Plunges After Q1 2026 Miss: What the Latest Sell-Off Really Means for Investors

AutoZone (AZO) Stock Plunges After Q1 2026 Miss: What the Latest Sell-Off Really Means for Investors

AutoZone (NYSE: AZO) stock is having a rough week. After reporting fiscal Q1 2026 earnings that showed healthy sales growth but weaker profits and margins, shares tumbled about 6–7% on Tuesday, December 9, making AutoZone the worst performer in the S&P 500 that day. Barron’s The selling has continued into Wednesday, December 10. AZO is recently trading around $3,400 per…
10 December 2025
····
Bank of America (BAC) Stock on Fed Cut Watch: Buffett Trims, Wall Street Stays Bullish – December 10, 2025

Bank of America (BAC) Stock on Fed Cut Watch: Buffett Trims, Wall Street Stays Bullish – December 10, 2025

As the Federal Reserve heads into its final policy decision of 2025, Bank of America Corporation (NYSE: BAC) is trading near its 52‑week high, backed by strong earnings, higher net interest income guidance, and ongoing optimism from Wall Street—even as Warren Buffett continues to sell down his once-massive stake. Below is a detailed look at where BAC stock stands today,…
10 December 2025
····
Robinhood (HOOD) Stock Today: Insider Selling, Indonesia Expansion and 2026 Forecast After a 270% Rally

Robinhood (HOOD) Stock Today: Insider Selling, Indonesia Expansion and 2026 Forecast After a 270% Rally

Robinhood Markets, Inc. (NASDAQ: HOOD) has gone from meme‑era punchline to one of 2025’s hottest S&P 500 stocks. After a year of spectacular gains, new international deals and record earnings, the stock is now wrestling with a different set of questions: how much of the good news is already priced in, and what comes next? As of mid‑day on December…
10 December 2025
···
Carvana Stock (CVNA) Soars on S&P 500 Inclusion: Latest News, Analyst Targets and 2026 Outlook

Carvana Stock (CVNA) Soars on S&P 500 Inclusion: Latest News, Analyst Targets and 2026 Outlook

December 10, 2025 – Carvana Co. (NYSE: CVNA) Carvana stock is back in the spotlight after a jaw‑dropping turnaround: from a near‑penny‑stock in late 2022 to a newly minted member of the S&P 500 with a market value that now rivals and even surpasses Detroit’s auto giants. As of Wednesday, Carvana shares are trading in the mid‑$450s, near an all‑time…
10 December 2025
·····
Palantir Stock (PLTR) Jumps on $448 Million U.S. Navy Deal: Latest Price, News, and 2025–2026 Forecasts (Updated December 10, 2025)

Palantir Stock (PLTR) Jumps on $448 Million U.S. Navy Deal: Latest Price, News, and 2025–2026 Forecasts (Updated December 10, 2025)

Palantir Technologies Inc. (NYSE: PLTR) is back in the spotlight today as a wave of fresh news, big new defense contracts, and sharply divided Wall Street opinions collide around one of the market’s hottest artificial intelligence stocks. On December 10, 2025, Palantir shares are trading just below recent highs after the company won a $448 million ShipOS contract with the…
10 December 2025
····
AeroVironment (AVAV) Stock on December 10, 2025: Record Q2 Revenue, $874M Army Deal and Fresh Wall Street Targets

AeroVironment (AVAV) Stock on December 10, 2025: Record Q2 Revenue, $874M Army Deal and Fresh Wall Street Targets

AeroVironment, Inc. (NASDAQ: AVAV), the U.S. drone and defense technology specialist, is in focus on 10 December 2025 after delivering record fiscal Q2 2026 revenue, raising its full‑year sales outlook and securing an $874 million U.S. Army contract, even as the share price trades far below its October peak. FinancialContent This piece pulls together the latest news, earnings, guidance, analyst…
10 December 2025
·····
JPMorgan Chase Stock Tumbles on 2026 Cost Shock: What JPM Investors Need to Know Today

JPMorgan Chase Stock Tumbles on 2026 Cost Shock: What JPM Investors Need to Know Today

December 10, 2025 — JPMorgan Chase & Co. (NYSE: JPM) is under pressure after warning that its 2026 expenses will be far higher than Wall Street expected, sending the stock to its biggest one-day drop in eight months and making it the worst performer in the Dow. Financial Times This article rounds up the latest news, forecasts, and professional as…
10 December 2025
····
1 … 402 403 404 405 406 … 564

Stock Market Today

  • Poxel S.A. Stock Drops 17.19% on EURONEXT Amid Weak Biotech Momentum
    February 4, 2026, 7:59 AM EST. Poxel S.A. (POXEL.PA) shares plunged 17.19% intraday to €0.316 on EURONEXT on 04 Feb 2026, pressured by weak near-term momentum in the biotech sector and concerns over small market cap of €18.7 million. Trading volume surged above the 50-day average, highlighting increased selling. Key financials indicate persistent losses, with EPS at -0.26 and a negative price-to-earnings ratio. Technical indicators suggest short-term support near €0.31 but volatile trading ahead of anticipated earnings on 25 Mar 2026. Meyka AI assigns a hold rating with a score of 60.87/100, projecting a price decline to €0.26 over the year while noting fundamental and liquidity challenges for the clinical-stage biotech.
Go toTop